Included in the formulation
АТХ:N.05.C.H.01 Melatonin
N.05.C.H Melatonin receptor agonists
Pharmacodynamics:Pineal gland hormone (epiphysis), a metabolite of serotonin; binding to melatonin 1A-receptors: inhibition of adenylate cyclase and activation of phospholipase C, leading to an increase in the concentration γ-aminobutyric acid and serotonin in the middle brain and hypothalamus, an increase in the activity of pyridoxal kinase, an enzyme involved in the synthesis γ-aminobutyric acid, serotonin and dopamine. It is secreted by the body at night, affecting sleep.
Pharmacokinetics:Absorption is variable. Biotransformation in the liver, half-life is 35-50 minutes.
Indications:Sleep disorders, fatigue, dEpressive syndrome, desynchronosis.
V.F50-F59.F51.0 Insomnia inorganic etiology
VI.G40-G47.G47.0 Disturbances of falling asleep and maintaining sleep [insomnia]
XVIII.R50-R69.R53 Malaise and fatigue
XXI.Z70-Z76.Z73.6 Limitations of activities caused by a decrease or loss of ability to work
Contraindications:Chronic renal failure, aallergic diseases, aimmune disorders, limphogranulomatosis, leukemia, lymphoma, myeloma, epilepsy, fromdiabetes mellitus, bPregnancy and breastfeeding.
Pregnancy and lactation:The category of FDA recommendations is not defined. The drug has a weak contraceptive effect, which should be informed by patients who want to become pregnant. Contraindicated in pregnancy and lactation.
Dosing and Administration:Assign inside by 1-5 mg once a day for 30-40 minutes before bedtime.
Side effects:Nervous system: headache.
Digestive system: nausea, vomiting, diarrhea.
Allergic reactions.
Overdose:In case of an overdose, there is an increase in side effects, gastric lavage, symptomatic therapy.
Interaction:With simultaneous use, it enhances the effects of drugs that depress CNS and beta-blockers.Incompatible with inhibitors MAO, glucocorticoids, cyclosporin.
Special instructions:It is not recommended to combine non-steroidal anti-inflammatory agents, drugs depressing CNS and beta-blockers. Do not use during work drivers of vehicles and people whose profession is associated with increased concentration of attention.
The drug has a weak contraceptive effect.
It is recommended to avoid bright lighting during treatment.